{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T09:20:28Z","timestamp":1770369628807,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Medical Award Foundation of China","award":["YXJL-2024-0039-0443"],"award-info":[{"award-number":["YXJL-2024-0039-0443"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03673-2","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T14:53:03Z","timestamp":1770130383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["XBP1-driven proliferative B cell subcluster in Diffuse\u00a0Large\u00a0B\u00a0Cell\u00a0Lymphoma linked to altered nucleotide metabolism"],"prefix":"10.1186","volume":"31","author":[{"given":"Li","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolian","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meijing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"issue":"4","key":"3673_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMoa2115304","volume":"386","author":"H Tilly","year":"2022","unstructured":"Tilly H, Morschhauser F, Sehn LH, Friedberg JW, Trn\u011bn\u00fd M, Sharman JP, et al. Polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma. N Engl J Med. 2022;386(4):351\u201363.","journal-title":"N Engl J Med"},{"issue":"5","key":"3673_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1053\/j.seminhematol.2023.11.004","volume":"60","author":"SS Wang","year":"2023","unstructured":"Wang SS. Epidemiology and etiology of diffuse large B-cell lymphoma. Semin Hematol. 2023;60(5):255\u201366.","journal-title":"Semin Hematol"},{"issue":"12","key":"3673_CR3","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","volume":"116","author":"B Coiffier","year":"2010","unstructured":"Coiffier B, Thieblemont C, Van Den Neste E, Lepeu G, Plantier I, Castaigne S, et al. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte. Blood. 2010;116(12):2040\u20135.","journal-title":"Blood"},{"issue":"3","key":"3673_CR4","doi-asserted-by":"publisher","first-page":"848","DOI":"10.7150\/ijbs.91154","volume":"20","author":"R Shao","year":"2024","unstructured":"Shao R, Liu C, Xue R, Deng X, Liu L, Song C, et al. Tumor-derived exosomal ENO2 modulates polarization of tumor-associated macrophages through reprogramming glycolysis to promote progression of diffuse large B-cell lymphoma. Int J Biol Sci. 2024;20(3):848\u201363.","journal-title":"Int J Biol Sci"},{"issue":"14","key":"3673_CR5","doi-asserted-by":"publisher","first-page":"7066","DOI":"10.1111\/jcmm.16720","volume":"25","author":"H Wang","year":"2021","unstructured":"Wang H, Shao R, Liu W, Tang H, Lu Y. Identification of a prognostic metabolic gene signature in diffuse large B-cell lymphoma. J Cell Mol Med. 2021;25(14):7066\u201377.","journal-title":"J Cell Mol Med"},{"key":"3673_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21062081","author":"P Klener","year":"2020","unstructured":"Klener P, Klanova M. Drug resistance in non-Hodgkin lymphomas. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21062081.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3673_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1515\/oncologie-2023-0459","volume":"26","author":"L Meng","year":"2024","unstructured":"Meng L, Zheng Y, Liu H, Fan D. The tumor microenvironment: a key player in multidrug resistance in cancer. Oncologie. 2024;26(1):41\u201358.","journal-title":"Oncologie"},{"key":"3673_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2147\/CMAR.S400013","volume":"15","author":"J Zhang","year":"2023","unstructured":"Zhang J, Gu Y, Chen B. Drug-resistance mechanism and new targeted drugs and treatments of relapse and refractory DLBCL. Cancer Manag Res. 2023;15:245\u201355.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"3673_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37273-4","volume":"9","author":"LM Fornecker","year":"2019","unstructured":"Fornecker LM, Muller L, Bertrand F, Paul N, Pichot A, Herbrecht R, et al. Multi-omics dataset to decipher the complexity of drug resistance in diffuse large B-cell lymphoma. Sci Rep. 2019;9(1):895.","journal-title":"Sci Rep"},{"key":"3673_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1146\/annurev-immunol-101220-015603","volume":"40","author":"SM Downs-Canner","year":"2022","unstructured":"Downs-Canner SM, Meier J, Vincent BG, Serody JS. B cell function in the tumor microenvironment. Annu Rev Immunol. 2022;40:169\u201393.","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"3673_CR11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ccell.2023.02.017","volume":"41","author":"CM Laumont","year":"2023","unstructured":"Laumont CM, Nelson BH. B cells in the tumor microenvironment: multi-faceted organizers, regulators, and effectors of anti-tumor immunity. Cancer Cell. 2023;41(3):466\u201389.","journal-title":"Cancer Cell"},{"issue":"5","key":"3673_CR12","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41577-019-0257-x","volume":"20","author":"GV Sharonov","year":"2020","unstructured":"Sharonov GV, Serebrovskaya EO, Yuzhakova DV, Britanova OV, Chudakov DM. B cells, plasma cells and antibody repertoires in the tumour microenvironment. Nat Rev Immunol. 2020;20(5):294\u2013307.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"3673_CR13","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.ccell.2021.08.011","volume":"39","author":"CB Steen","year":"2021","unstructured":"Steen CB, Luca BA, Esfahani MS, Azizi A, Sworder BJ, Nabet BY, et al. The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma. Cancer Cell. 2021;39(10):1422-1437.e1410.","journal-title":"Cancer Cell"},{"issue":"3","key":"3673_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110713","volume":"39","author":"X Ye","year":"2022","unstructured":"Ye X, Wang L, Nie M, Wang Y, Dong S, Ren W, et al. A single-cell atlas of diffuse large B cell lymphoma. Cell Rep. 2022;39(3):110713.","journal-title":"Cell Rep"},{"issue":"1","key":"3673_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01659-2","volume":"8","author":"Y Wang","year":"2023","unstructured":"Wang Y, Tong C, Lu Y, Wu Z, Guo Y, Liu Y, et al. Characteristics of premanufacture CD8(+)T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma. Signal Transduct Target Ther. 2023;8(1):409.","journal-title":"Signal Transduct Target Ther"},{"issue":"16","key":"3673_CR16","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1182\/bloodadvances.2022007493","volume":"6","author":"AR Colombo","year":"2022","unstructured":"Colombo AR, Hav M, Singh M, Xu A, Gamboa A, Lemos T, et al. Single-cell spatial analysis of tumor immune architecture in diffuse large B-cell lymphoma. Blood Adv. 2022;6(16):4675\u201390.","journal-title":"Blood Adv"},{"issue":"23","key":"3673_CR17","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1158\/1078-0432.CCR-23-1554","volume":"29","author":"ZY Xu-Monette","year":"2023","unstructured":"Xu-Monette ZY, Li Y, Snyder T, Yu T, Lu T, Tzankov A, et al. Tumor-infiltrating normal B cells revealed by immunoglobulin repertoire clonotype analysis are highly prognostic and crucial for antitumor immune responses in DLBCL. Clin Cancer Res. 2023;29(23):4808\u201321.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"3673_CR18","doi-asserted-by":"publisher","first-page":"611","DOI":"10.32604\/chd.2023.047689","volume":"18","author":"A Zulibiya","year":"2023","unstructured":"Zulibiya A, Wen J, Yu H, Chen X, Xu L, Ma X, et al. Single-cell RNA sequencing reveals potential for endothelial-to-mesenchymal transition in Tetralogy of Fallot. Congenit Heart Dis. 2023;18(6):611\u201325.","journal-title":"Congenit Heart Dis"},{"issue":"12","key":"3673_CR19","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16(12):1289\u201396.","journal-title":"Nat Methods"},{"issue":"4","key":"3673_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1515\/oncologie-2024-0074","volume":"26","author":"S Gao","year":"2024","unstructured":"Gao S, Shi X, Yue C, Chen Y, Zuo L, Wang S. Comprehensive analysis of competing endogenous RNA networks involved in the regulation of glycolysis in clear cell renal cell carcinoma. Oncologie. 2024;26(4):587\u2013602.","journal-title":"Oncologie"},{"issue":"1","key":"3673_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05313-5","volume":"22","author":"L Wang","year":"2024","unstructured":"Wang L, Li X, Xu C, Wang D, Ma C, Wang Z, et al. Unveiling novel cell clusters and biomarkers in glioblastoma and its peritumoral microenvironment at the single-cell perspective. J Transl Med. 2024;22(1):551.","journal-title":"J Transl Med"},{"issue":"5","key":"3673_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. ClusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284\u20137.","journal-title":"Omics"},{"key":"3673_CR23","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429322420241112051105","author":"S Fatima","year":"2024","unstructured":"Fatima S, Song Y, Zhang Z, Fu Y, Zhao R, Malik K, et al. Exploring the pharmacological mechanisms of P-hydroxylcinnamaldehyde for treating gastric cancer: a pharmacological perspective with experimental confirmation. Curr Mol Pharmacol. 2024. https:\/\/doi.org\/10.2174\/0118761429322420241112051105.","journal-title":"Curr Mol Pharmacol"},{"issue":"1","key":"3673_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12(1):1088.","journal-title":"Nat Commun"},{"issue":"11","key":"3673_CR25","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S, Gonz\u00e1lez-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G, et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods. 2017;14(11):1083\u20136.","journal-title":"Nat Methods"},{"issue":"2","key":"3673_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2174\/0115665232258527230919071328","volume":"24","author":"Y Ning","year":"2024","unstructured":"Ning Y, Zhou X, Wang G, Zhang L, Wang J. Exosome miR-30a-5p regulates glomerular endothelial cells\u2019 endMT and angiogenesis by modulating Notch1\/VEGF signaling pathway. Curr Gene Ther. 2024;24(2):159\u201377.","journal-title":"Curr Gene Ther"},{"issue":"4","key":"3673_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (San Diego, Calif). 2001;25(4):402\u20138.","journal-title":"Methods (San Diego, Calif.)"},{"issue":"3","key":"3673_CR28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2174\/1573412919666221223152915","volume":"19","author":"L Zhang","year":"2023","unstructured":"Zhang L, Yang H, Liu J, Wang K, Cai X, Xiao W, et al. Metabolomics-based approach to analyze the therapeutic targets and metabolites of a synovitis ointment for knee osteoarthritis. Curr Pharm Anal. 2023;19(3):222\u201334.","journal-title":"Curr Pharm Anal"},{"issue":"2","key":"3673_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12016-017-8609-4","volume":"53","author":"TE Taher","year":"2017","unstructured":"Taher TE, Bystrom J, Ong VH, Isenberg DA, Renaudineau Y, Abraham DJ, et al. Intracellular B lymphocyte signalling and the regulation of humoral immunity and autoimmunity. Clin Rev Allergy Immunol. 2017;53(2):237\u201364.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"3673_CR30","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bj.2021.02.003","volume":"44","author":"O P\u00f6s","year":"2021","unstructured":"P\u00f6s O, Radvanszky J, Bugly\u00f3 G, P\u00f6s Z, Rusnakova D, Nagy B, et al. DNA copy number variation: main characteristics, evolutionary significance, and pathological aspects. Biomed J. 2021;44(5):548\u201359.","journal-title":"Biomed J"},{"issue":"2","key":"3673_CR31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00277-015-2552-3","volume":"95","author":"E Sebasti\u00e1n","year":"2016","unstructured":"Sebasti\u00e1n E, Alcoceba M, Mart\u00edn-Garc\u00eda D, Blanco \u00d3, Sanchez-Barba M, Balanzategui A, et al. High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma. Ann Hematol. 2016;95(2):253\u201362.","journal-title":"Ann Hematol"},{"issue":"12","key":"3673_CR32","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1038\/leu.2016.135","volume":"30","author":"D Juskevicius","year":"2016","unstructured":"Juskevicius D, Lorber T, Gsponer J, Perrina V, Ruiz C, Stenner-Liewen F, et al. Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis. Leukemia. 2016;30(12):2385\u201395.","journal-title":"Leukemia"},{"key":"3673_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12030648","author":"L Gergely","year":"2024","unstructured":"Gergely L, Udvardy M, Illes A. The possible role of pathogens and chronic immune stimulation in the development of diffuse large B-cell lymphoma. Biomedicines. 2024. https:\/\/doi.org\/10.3390\/biomedicines12030648.","journal-title":"Biomedicines"},{"key":"3673_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13060734","author":"J Wu","year":"2023","unstructured":"Wu J, Meng F, Ran D, Song Y, Dang Y, Lai F, et al. The metabolism and immune environment in diffuse large B-cell lymphoma. Metabolites. 2023. https:\/\/doi.org\/10.3390\/metabo13060734.","journal-title":"Metabolites"},{"key":"3673_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030835","author":"T Takahara","year":"2023","unstructured":"Takahara T, Nakamura S, Tsuzuki T, Satou A. The immunology of DLBCL. Cancers. 2023. https:\/\/doi.org\/10.3390\/cancers15030835.","journal-title":"Cancers"},{"issue":"1","key":"3673_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01263-x","volume":"15","author":"HL Wu","year":"2022","unstructured":"Wu HL, Gong Y, Ji P, Xie YF, Jiang YZ, Liu GY. Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy. J Hematol Oncol. 2022;15(1):45.","journal-title":"J Hematol Oncol"},{"key":"3673_CR37","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.2147\/IJGM.S414106","volume":"16","author":"D Berta","year":"2023","unstructured":"Berta D, Girma M, Melku M, Adane T, Birke B, Yalew A. Role of RNA splicing mutations in diffuse large B cell lymphoma. Int J Gen Med. 2023;16:2469\u201380.","journal-title":"Int J Gen Med"},{"issue":"2","key":"3673_CR38","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cancergencyto.2009.01.003","volume":"190","author":"G Tate","year":"2009","unstructured":"Tate G, Kishimoto K, Hirayama Y, Suzuki T, Mitsuya T. A novel missense mutation of the XBP1 gene in diffuse large B-cell lymphoma. Cancer Genet Cytogenet. 2009;190(2):131\u20133.","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"3673_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01992-y","volume":"21","author":"Y Cui","year":"2021","unstructured":"Cui Y, Xu H, Yang Y, Zhao D, Wen Y, Lv C, et al. The regulation of miR-320a\/XBP1 axis through LINC00963 for endoplasmic reticulum stress and autophagy in diffuse large B-cell lymphoma. Cancer Cell Int. 2021;21(1):305.","journal-title":"Cancer Cell Int"},{"key":"3673_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1250719","volume":"14","author":"S Horiuchi","year":"2023","unstructured":"Horiuchi S, Koike T, Takebuchi H, Hoshino K, Sasaki I, Fukuda-Ohta Y, et al. SpiB regulates the expression of B-cell-related genes and increases the longevity of memory B cells. Front Immunol. 2023;14:1250719.","journal-title":"Front Immunol"},{"issue":"9","key":"3673_CR41","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1111\/cas.13001","volume":"107","author":"Y Takagi","year":"2016","unstructured":"Takagi Y, Shimada K, Shimada S, Sakamoto A, Naoe T, Nakamura S, et al. SPIB is a novel prognostic factor in diffuse large B-cell lymphoma that mediates apoptosis via the PI3K-AKT pathway. Cancer Sci. 2016;107(9):1270\u201380.","journal-title":"Cancer Sci"},{"issue":"3","key":"3673_CR42","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1182\/blood.2020010039","volume":"139","author":"B Eluard","year":"2022","unstructured":"Eluard B, Nuan-Aliman S, Faumont N, Collares D, Bordereaux D, Montagne A, et al. The alternative RelB NF-\u03baB subunit is a novel critical player in diffuse large B-cell lymphoma. Blood. 2022;139(3):384\u201398.","journal-title":"Blood"},{"key":"3673_CR43","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028423","author":"H Negishi","year":"2018","unstructured":"Negishi H, Taniguchi T, Yanai H. The Interferon (IFN) Class of Cytokines and the IFN Regulatory Factor (IRF) Transcription Factor Family. Cold Spring Harbor perspectives in biology. 2018. https:\/\/doi.org\/10.1101\/cshperspect.a028423.","journal-title":"Cold Spring Harbor perspectives in biology"},{"key":"3673_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/cells12010196","author":"M Ejtehadifar","year":"2023","unstructured":"Ejtehadifar M, Zahedi S, Gameiro P, Cabe\u00e7adas J, da Silva MG, Beck HC, et al. Meta-analysis of MS-based proteomics studies indicates interferon regulatory factor 4 and nucleobindin1 as potential prognostic and drug resistance biomarkers in diffuse large B cell lymphoma. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12010196.","journal-title":"Cells"},{"key":"3673_CR45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.intimp.2016.04.018","volume":"36","author":"JZ Wang","year":"2016","unstructured":"Wang JZ, Zhang YH, Guo XH, Zhang HY, Zhang Y. The double-edge role of B cells in mediating antitumor T-cell immunity: pharmacological strategies for cancer immunotherapy. Int Immunopharmacol. 2016;36:73\u201385.","journal-title":"Int Immunopharmacol"},{"key":"3673_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.100966","volume":"48","author":"Q Wang","year":"2024","unstructured":"Wang Q, Liu W, Zhou H, Lai W, Hu C, Dai Y, et al. Tozasertib activates anti-tumor immunity through decreasing regulatory T cells in melanoma. Neoplasia (New York, NY). 2024;48:100966.","journal-title":"Neoplasia (New York, N.Y.)"},{"issue":"3","key":"3673_CR47","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/aje\/kwp383","volume":"171","author":"CF Skibola","year":"2010","unstructured":"Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjos\u00e9 S, Hughes AM, et al. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph consortium. Am J Epidemiol. 2010;171(3):267\u201376.","journal-title":"Am J Epidemiol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03673-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03673-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03673-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T18:00:06Z","timestamp":1770314406000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03673-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3673"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03673-2","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for this study because it does not involve any human experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"226"}}